Previous in vivo and in vitro studies using head and neck cancer cells found that combined treatment of cisplatin and curcumin inhibited tumor angiogenesis by 62%, VEGF production by 83%, STAT3 phosphorylation by 94%, and CAL27-CisR tumor growth by 77% compared to the non-treated group [90]. This evidence concerns the gene VEGFA and neoplasm.